Eli Lilly wants to incentivize more employers to cover GLP-1s
Lilly will offer Zepbound, an injectable GLP-1 medication, at a price of $449 per month through a platform called Lilly Connect.
Master compensation and benefits. Stay updated on Benefits Strategy trends, strategies, and industry benchmarks with HR Brew.
Lilly will offer Zepbound, an injectable GLP-1 medication, at a price of $449 per month through a platform called Lilly Connect.
HR teams are under increasing pressure to demonstrate a return-on-investment from benefits, but calculating it can be complicated.
Nearly three-quarters said they were moderately, very, or extremely concerned about pharmacy costs being “unsustainable,” despite legislative efforts to temper them.
Think of it as “a strategic moment to actually engage with employees,” Prudential Group Insurance’s head of enrollment says.
Organizations are holding off on plans to cover GLP-1s for weight loss in the future, if they aren’t already doing so.
From recruiting and retention to company culture and the latest in HR tech, HR Brew delivers up-to-date industry news and tips to help HR pros stay nimble in today’s fast-changing business environment.
By subscribing, you accept our Terms & Privacy Policy.